Xin Lu - Curriculum Vitae#
Education:
- 1991 PhD in Cell and Molecular Biology, Imperial Cancer Research Fund and University College London, London, UK
- 1985 MSc in Cell and Molecular Biology, Cancer Institute, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, P. R. China
- 1982 BSc in Biochemistry, Sichuan University, P.R. China
Committees and Associations:
1. Scientific Advisory and Selection Committees:
- 2021 Istituto Toscano Tumori (ITT) Italy ISAB member
- 2010 - present Medical Sciences Division Board Member, University of Oxford, UK
- 2013 - present Academy of Medical Sciences, Selection Committee
- 2011 Carcinogenesis Prize Selection Committee, UK
- 2010 Molecular Medicine Advisory/Review Panel Member, The Nordic Centre of Excellence Programme
- 2008 - 2010 Scientific Advisory/Review Board Member, Institute of Molecular and Cell Biology, Singapore
- 2006 - 2009 Advisory Panel Member, CR-UK China Fellowships Programme, UK
2. Institute Review Committees
- 2020 The ‘Genes and Society’ and ‘Neuroscience’ Research Themes Review for Trinity College Dublin
- 2014-2016 International Review, Peking University School of Life Sciences, China
- 2010-present International Review, Tsinghua University, China
- 2009 MRC Epigenetics, Development and Cancer Section, Imperial College, London, UK
- 2008-present International review, Chinese Academy of Science, China
- 2008 MRC Induced Pluripotent Stem Cells Review Board, UK
- 2008 MRC Models of Disease Panel, UK
- 2008 MRC Genome Damage and Stability Centre Review, UK
- 2008 Cesar Milstein Chair Electoral Board, University of Oxford, UK
- 2007 - 2008 MRC Oncology Showcase Pilot Industry Collaboration Award Scheme, UK
3. Grant Committees
- 2020 Swedish Research Council Review Panel for “Grants for Distinguished Professors”
- 2012 - present European Research Council (ERC) Consolidator Panel
- 2011 - 2015 Cancer Research UK New Investigator Awards Panel, UK
- 2007 Committee Member, Deutsche Forschungsgemeinschaft (DFG), Center of Excellence, Germany
- 2006 - 2011 MRC Molecular and Cellular Medicine Board (MCMB), UK
- 2006 - 2009 Chair of Cancer Biology Review Panel, Academy of Finland
- 2006 - 2009 Several International PhD Examination Committees in Lausanne and Stockholm
- 2006 Hong Kong Research Council Biomedical Panel, China
- 2005 - 2006 Chairman, Chinese Life Science Society in UK, UK
- 2004 - 2007 Scientific Grant Committee Member, Association for International Cancer Research (AICR), UK
4. Editorial Board Memberships:
- 2014 - present Cell Death and Differentiation, Receiving Editor
- 2009 - present Cell Death and Disease, Editorial Board Member
- 2008 - present Oncogene, Receiving Editor
- 2008 - 2011 Carcinogenesis, Editorial Board Member
- 2005 - 2011 Cell Research, Editorial Board Member
5. Meetings Organised (2007-2016):
- 2016 National Cancer Research Institute (NCRI) Conference Committee Member
- 2016 Nature Conference, Nuclear Reprogramming and the Cancer Genome, San Diego
- 2015 ICG-10: the 10th International Conference of Cancer Genomics, Shenzhen
- 1st CRUK International Oesophageal Cancer Symposium
- 2014 Chinese Academy of Sciences-Nature Conference: Nuclear Reprogramming and Cancer Epigenetics, Guangzhou
- Joint Conference of ICG-9 and the 3rd Shenzhen International Biotechnology Innovation Forum & Expo, Shenzhen
- Single Cell Sequencing Workshop, Oxford, UK
- 2013 Ludwig-Nature Conference: Nuclear Reprogramming of the Cancer Genome, Oxford, UK
- 2011 Cell Polarity in Health and Disease, Oxford, UK
- 3rd Sino-British Frontier Workshop of Cancer Biology, Shanghai, China
- 2010 2nd Sino-British Frontier Workshop of Cancer Biology, Shanghai, China
- 2008 14th International p53 Workshop, Shanghai, China
- Chinese Academy of Science – Morningside Symposium, Kunming, China
- Keystone Symposium – Stem Cells, Cancer and Ageing, Singapore
- 1st Sino-British Frontier Workshop of Cancer Biology, Shanghai, China
- 2007 University of Oxford Medical Sciences Division, Science Day, Development, Differentiation & Malignancy, Oxford, UK
- Mdm2 Workshop, Boston, USA
Patents:
- LUD5649 Suppressor Genes 04/8/00
- LUD5868 iASPP 07/10/02
- LUD5829 iASPP Polypeptide 07/10/02
- LUD6098 iASPP Phosphorylation and Metastatic Potential 03/02/12
